SCIE(SCI)期刊ANNALS OF PHARMACOTHERAPY(ANN PHARMACOTHER)影響因子@(藥理學(xué)與藥學(xué))學(xué)科排名
SCIE(SCI)期刊ANNALS OF PHARMACOTHERAPY(20 21 REV HIST)總引論文
SCIE(SCI)期刊ANNALS OF PHARMACOTHERAPY(ANN PHARMACOTHER)總引論文@(藥理學(xué)與藥學(xué))學(xué)科排名
SCIE(SCI)期刊ANNALS OF PHARMACOTHERAPY(20 21 REV HIST)影響因子
SCIE(SCI)期刊ANNALS OF PHARMACOTHERAPY(ANN PHARMACOTHER)總引頻次@(藥理學(xué)與藥學(xué))學(xué)科排名
SCIE(SCI)期刊ANNALS OF PHARMACOTHERAPY(20 21 REV HIST)即時影響因子
SCIE(SCI)期刊ANNALS OF PHARMACOTHERAPY(ANN PHARMACOTHER)即時影響因子@(藥理學(xué)與藥學(xué))學(xué)科排名
SCIE(SCI)期刊ANNALS OF PHARMACOTHERAPY(20 21 REV HIST)五年累積影響因子
SCIE(SCI)期刊ANNALS OF PHARMACOTHERAPY(ANN PHARMACOTHER)五年累積影響因子@(藥理學(xué)與藥學(xué))學(xué)科排名
作者: 突變 時間: 2025-3-22 00:13 作者: 亞當(dāng)心理陰影 時間: 2025-3-22 00:22
Submitted on: 31 October 2016.
Revised on: 28 January 2017.
Accepted on: 24 February 2017.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: Optic-Disk 時間: 2025-3-22 07:14
Submitted on: 20 May 2002.
Revised on: 29 July 2002.
Accepted on: 01 September 2002.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: 投票 時間: 2025-3-22 10:53 作者: Postulate 時間: 2025-3-22 14:42 作者: Enzyme 時間: 2025-3-22 17:46
Submitted on: 05 January 2001.
Revised on: 02 February 2001.
Accepted on: 19 March 2001.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: 子女 時間: 2025-3-22 21:52 作者: CT-angiography 時間: 2025-3-23 04:25
Submitted on: 31 May 2021.
Revised on: 23 September 2021.
Accepted on: 16 October 2021.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: 存在主義 時間: 2025-3-23 06:52
Submitted on: 15 October 2013.
Revised on: 05 February 2014.
Accepted on: 29 March 2014.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: CARK 時間: 2025-3-23 11:12
Submitted on: 06 November 2012.
Revised on: 01 January 2013.
Accepted on: 05 February 2013.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: Common-Migraine 時間: 2025-3-23 14:37 作者: enumaerate 時間: 2025-3-23 19:22 作者: insomnia 時間: 2025-3-24 00:54
Submitted on: 22 March 2019.
Revised on: 01 May 2019.
Accepted on: 11 May 2019.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: 灌輸 時間: 2025-3-24 02:51 作者: 相同 時間: 2025-3-24 10:01 作者: PACK 時間: 2025-3-24 11:46 作者: 無能力之人 時間: 2025-3-24 18:15 作者: Isolate 時間: 2025-3-24 19:14
Submitted on: 11 August 2009.
Revised on: 03 November 2009.
Accepted on: 23 December 2009.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: evince 時間: 2025-3-24 23:51 作者: 變白 時間: 2025-3-25 05:14
Submitted on: 01 July 2006.
Revised on: 23 October 2006.
Accepted on: 29 November 2006.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: apropos 時間: 2025-3-25 09:13 作者: Ambulatory 時間: 2025-3-25 14:07
Submitted on: 12 January 2024.
Revised on: 16 March 2024.
Accepted on: 15 April 2024.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: enmesh 時間: 2025-3-25 19:52 作者: 概觀 時間: 2025-3-25 22:06 作者: Genome 時間: 2025-3-26 00:32 作者: instate 時間: 2025-3-26 07:00
Submitted on: 15 March 2013.
Revised on: 10 May 2013.
Accepted on: 20 June 2013.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: lipoatrophy 時間: 2025-3-26 11:54 作者: Fatten 時間: 2025-3-26 16:32 作者: 針葉類的樹 時間: 2025-3-26 20:48 作者: exclusice 時間: 2025-3-26 21:35
Submitted on: 16 February 2011.
Revised on: 12 April 2011.
Accepted on: 17 May 2011.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: 即席 時間: 2025-3-27 01:25 作者: Generosity 時間: 2025-3-27 06:20 作者: overshadow 時間: 2025-3-27 12:03
Submitted on: 11 January 2004.
Revised on: 07 April 2004.
Accepted on: 12 May 2004.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: Oversee 時間: 2025-3-27 14:55
Submitted on: 08 February 2021.
Revised on: 10 May 2021.
Accepted on: 14 June 2021.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC作者: 燒瓶 時間: 2025-3-27 18:49
Submitted on: 24 October 2014.
Revised on: 28 January 2015.
Accepted on: 13 February 2015.
___________________ANNALS OF PHARMACOTHERAPY---SAGE PUBLICATIONS INC
